Has the Genome Granted Our Wish Yet?

Interpretation of polygenic risk scores will someday become an accepted part of clinical practice - but not just yet. It is, however, time to evaluate these scores in studies that assess clinical utility, benefits and costs, and scalable risk-communication methods.